Codon-optimzed hepatitis B virus core antigen (HBcAg)

Details for Australian Patent Application No. 2010332400 (hide)

Owner Chrontech Pharma AB

Inventors Sallberg, Matti; Frelin, Lars

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010332400

PCT Pub. Number WO2011/073796

Priority 61/292,374 05.01.10 US; 61/287,160 16.12.09 US

Filing date 14 December 2010

Wipo publication date 23 June 2011

International Classifications

C07K 14/18 Peptides having more than 20 amino acids

A61B 17/06 Surgery - Needles

A61K 39/29 Medicinal preparations containing antigens or antibodies - Hepatitis virus

A61M 5/158 Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way

A61M 5/32 Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way - Needles

Event Publications

19 July 2012 PCT application entered the National Phase

  PCT publication WO2011/073796 Priority application(s): WO2011/073796

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010332402-Method of producing a sulfide solid electrolyte material, sulfide solid electrolyte material, and lithium battery

2010332391-Wear part device for a work tool